e-learning
resources
ERJ
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Measurement of quality of life in pulmonary hypertension and its significance
Cenedese E., Speich R., Dorschner L., Ulrich S., Maggiorini M., Jenni R., Fischler M.
Source:
Eur Respir J 2006 Oct 01;28(4):808-815
Journal Issue:
October
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Cenedese E., Speich R., Dorschner L., Ulrich S., Maggiorini M., Jenni R., Fischler M.. Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J 2006 Oct 01;28(4):808-815
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Em
PH
asis-10 is associated with clinical outcome measures in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension
Source: Eur Respir J 2011; 38: 608-616
Year: 2011
Sildenafil improves health-related quality of life in pulmonary arterial hypertension (PAH) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 563s
Year: 2005
Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Effects of tadalafil on health-related quality of life in patients with pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009
Pulmonary arterial hypertension: the burden of disease and impact on quality of life
Source: Eur Respir Rev 2015; 24: 621-629
Year: 2015
The study of risk in pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21:234-238
Year: 2012
Impact of insomnia on exercise capacity and quality of life in patients with pulmonary arterial hypertension
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Health-related quality of life in patients with pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011
The influence of psycho-social factors in the evolution of pulmonary hypertension patients
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Quality of life and physical functioning in chronic thromboembolic pulmonary hypertension (CTEPH): the impact of treatment
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Dipyridamole as adjuvant therapy in patients with pulmonary arterial hypertension. A pilot study
Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Year: 2007
emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension
Source: Eur Respir J 2014; 43: 1106-1113
Year: 2014
Exercise tests and anxiety independently reflect physical quality of life in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Disease-targeted treatment improves cognitive function in patients with pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
The effect of pulmonary rehabilitation on health-related quality of life in patients with pulmonary sarcoidosis
Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Year: 2018
Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study
Source: ERJ Open Res, 7 (3) 00617-2020; 10.1183/23120541.00617-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept